Cargando…

Pharmacokinetics and Exposure–Response of Vosoritide in Children with Achondroplasia

BACKGROUND AND OBJECTIVE: Vosoritide, an analog of C-type natriuretic peptide, has been developed for the treatment of children with achondroplasia. The pharmacokinetics of vosoritide and relationships between plasma exposure and efficacy, biomarkers, and safety endpoints were evaluated in a phase I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Ming Liang, Qi, Yulan, Larimore, Kevin, Cherukuri, Anu, Seid, Lori, Jayaram, Kala, Jeha, George, Fisheleva, Elena, Day, Jonathan, Huntsman-Labed, Alice, Savarirayan, Ravi, Irving, Melita, Bacino, Carlos A., Hoover-Fong, Julie, Ozono, Keiichi, Mohnike, Klaus, Wilcox, William R., Horton, William A., Henshaw, Joshua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813707/ https://www.ncbi.nlm.nih.gov/pubmed/34431071 http://dx.doi.org/10.1007/s40262-021-01059-1

Ejemplares similares

LBMON196 A Randomized Controlled Trial Of Vosoritide In Infants And Toddlers With Achondroplasia
por: Savarirayan, Ravi, et al.
Publicado: (2022)

Evidence of feedback regulation of C-type natriuretic peptide during Vosoritide therapy in Achondroplasia
por: Prickett, Timothy C. R., et al.
Publicado: (2021)

SAT-LB18 A Randomized Controlled Trial of Vosoritide in Children With Achondroplasia
por: Savarirayan, Ravi, et al.
Publicado: (2020)

Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study
por: Savarirayan, Ravi, et al.
Publicado: (2021)

Persistent and Stable Growth Promoting Effects of Vosoritide in Children With Achondroplasia for up to 2 Years: Results From the Ongoing Phase 3 Extension Study
por: Savarirayan, Ravi, et al.
Publicado: (2021)

Rationale, design, and methods of a randomized, controlled, open-label clinical trial with open-label extension to investigate the safety of vosoritide in infants, and young children with achondroplasia at risk of requiring cervicomedullary decompression surgery
por: Savarirayan, Ravi, et al.
Publicado: (2021)

Parents’ Experience of Administering Vosoritide: A Daily Injectable for Children with Achondroplasia
por: NiMhurchadha, Sinead, et al.
Publicado: (2023)

Literature review and expert opinion on the impact of achondroplasia on medical complications and health-related quality of life and expectations for long-term impact of vosoritide: a modified Delphi study
por: Savarirayan, Ravi, et al.
Publicado: (2022)

Experiences of children and adolescents living with achondroplasia and their caregivers
por: Shediac, Renée, et al.
Publicado: (2022)

SUN-093 Prospective Clinical Assessment Study in Children with Achondroplasia: The PROPEL Trial
por: Savarirayan, Ravi, et al.
Publicado: (2020)

PSAT103 Qualitative Research in Children with Achondroplasia and Parents of Children with Achondroplasia: Medical Challenges and Impacts
por: Muslimova, Elena, et al.
Publicado: (2022)

Optimising the diagnosis and referral of achondroplasia in Europe: European Achondroplasia Forum best practice recommendations
por: Cormier-Daire, Valerie, et al.
Publicado: (2022)

Hearing loss in Norwegian adults with achondroplasia
por: Fredwall, Svein O., et al.
Publicado: (2021)

The first European consensus on principles of management for achondroplasia
por: Cormier-Daire, Valerie, et al.
Publicado: (2021)

Optimal management of complications associated with achondroplasia
por: Ireland, Penny J, et al.
Publicado: (2014)

Optimising care and follow-up of adults with achondroplasia
por: Fredwall, Svein, et al.
Publicado: (2022)

Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies
por: Savarirayan, Ravi, et al.
Publicado: (2022)

Clinical Practice Guidelines for Achondroplasia*
por: Kubota, Takuo, et al.
Publicado: (2020)

Current knowledge of medical complications in adults with achondroplasia: A scoping review
por: Fredwall, Svein O., et al.
Publicado: (2019)

European Achondroplasia Forum guiding principles for the detection and management of foramen magnum stenosis
por: Irving, Melita, et al.
Publicado: (2023)

Quality of life of children with achondroplasia and their parents - a German cross-sectional study
por: Witt, Stefanie, et al.
Publicado: (2019)

Australian guidelines for the management of children with achondroplasia
por: Tofts, Louise J, et al.
Publicado: (2023)

Cardiovascular risk factors and body composition in adults with achondroplasia
por: Fredwall, Svein O., et al.
Publicado: (2020)

Achondroplasia
por: Hunter, Richard H.
Publicado: (1933)

Achondroplasia
por: Flemming, Charles E. S.
Publicado: (1899)

PSAT106 Infigratinib in Children with Achondroplasia: Design of the PROPEL, PROPEL2 and PROPEL OLE Studies
por: Muslimova, Elena, et al.
Publicado: (2022)

Correction to: Cardiovascular risk factors and body composition in adults with achondroplasia
por: Fredwall, Svein O., et al.
Publicado: (2021)

PSAT105 Evaluation of Body Mass Index and Metabolic Parameters in Children with Achondroplasia Participating in the PROPEL Study
por: Rogoff, Daniela, et al.
Publicado: (2022)

OR18-5 A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature
por: Boucher, Kimberly, et al.
Publicado: (2022)

Obstructive sleep apnea in Norwegian adults with achondroplasia: a population-based study
por: Fredwall, Svein O., et al.
Publicado: (2021)

Real-world evidence in achondroplasia: considerations for a standardized data set
por: Alanay, Yasemin, et al.
Publicado: (2023)

Burden and Treatment of Achondroplasia: A Systematic Literature Review
por: Murton, Molly C., et al.
Publicado: (2023)

Achondroplasia Natural History Study (CLARITY): a multicenter retrospective cohort study of achondroplasia in the United States
por: Hoover-Fong, Julie E., et al.
Publicado: (2021)

The Antiquity of Achondroplasia
por: Bleyer, Adrirn
Publicado: (1940)

RF26 | PMON326 Medical History of Children Enrolled in PROPEL: A Prospective Clinical Assessment Study in Children with Achondroplasia
por: Irving, Melita, et al.
Publicado: (2022)

Growth in achondroplasia including stature, weight, weight-for-height and head circumference from CLARITY: achondroplasia natural history study—a multi-center retrospective cohort study of achondroplasia in the US
por: Hoover-Fong, Julie E., et al.
Publicado: (2021)

THU165 PROPEL, PROPEL 2 And PROPEL OLE Studies Of Infigratinib In Children With Achondroplasia: Design And Status Of 3 Ongoing Trials
por: Savarirayan, Ravi, et al.
Publicado: (2023)

Inconvenience and adaptation in Japanese adult achondroplasia and hypochondroplasia: A cross-sectional study
por: Ajimi, Akiko, et al.
Publicado: (2021)

High prevalence of symptomatic spinal stenosis in Norwegian adults with achondroplasia: a population-based study
por: Fredwall, Svein O., et al.
Publicado: (2020)

Molecular studies of achondroplasia
por: Nahar, Risha, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_st012o1pa51qgg98lgmo38jgj4